Categories

Popular tags

View all
LessDrops
Pred-Moxi-Nepaf 5mL
Add this to my Favorites list

Pred-Moxi-Nepaf Suspension 5mL

(Prednisolone acetate 1%, moxifloxacin 0.5% and nepafenac 0.1%)
  • Unit Size: 5 ML
  • Package Size: 20 per Box
  • Package Price: $836.00

Shipped in boxes of 20.
Guaranteed expiration date of 60 days from date of receipt.
Click here to download the package insert.

SKU: 300000101948332
Manufacturer part number: LD050
*

Please select a clinical difference for this product.

*
Box(es) of 20
Specifications
  • NDC Number: 71384-0320-05
  • Classification: Topical Eye Drops
  • Sub-Classification: Suspension
  • Storage: Room Temperature
  • Unit Type: Bottle
Related Formulations
Pred-Moxi-Nepaf 8mL

Pred-Moxi-Nepaf Suspension 8mL

(Prednisolone acetate 1%, moxifloxacin 0.5% and nepafenac 0.1%)
  • Unit Size: 8 ML/Unit
  • Package Size: 20
  • Package Price: $1,540.00
Pred-Nepaf 5mL

Pred-Nepaf Suspension 5mL

(Prednisolone acetate 1%, nepafenac 0.1 %)
  • Unit Size: 5 ML/Unit
  • Package Size: 20
  • Package Price: $704.00
Klarity (Chondroitin Sulfate)

Klarity Drops®

Glycerin and dextran based vehicle ophthalmic solution PF)
  • Unit Size: 10 ML/Unit
  • Package Size: 20
  • Package Price: $352.00
Customers who bought this item also bought
Pred-Moxi-Nepaf 8mL

Pred-Moxi-Nepaf Suspension 8mL

(Prednisolone acetate 1%, moxifloxacin 0.5% and nepafenac 0.1%)
  • Unit Size: 8 ML/Unit
  • Package Size: 20
  • Package Price: $1,540.00
Pred-Moxi Suspension

Pred-Moxi Suspension 5mL

(Prednisolone acetate 1% and moxifloxacin 0.5%)
  • Unit Size: 5 ML/Unit
  • Package Size: 20
  • Package Price: $704.00
Mydriatic 2 Tropicamide and Phenylephrine

Mydriatic 2 Multi-Dose 10mL

(Tropicamide 1% and phenylephrine 2.5%)
  • Unit Size: 10 ML/Unit
  • Package Size: 10
  • Package Price: $275.00
Moxifloxacin 5mg/mL

Moxifloxacin Injectable 0.5%

(Moxifloxacin 5mg/mL)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $330.00
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.